Galaxy Surfactants Ltd. · NSE:GALAXYSURF

Galaxy Surfactants — Q2 FY2021 Earnings Presentation

46 slides from Galaxy Surfactants's earnings presentation, Nov 19, 2020

  1. Slide 1: Galaxy Surfactants Limited Investor Presentation - November 2020

    Galaxy Surfactants Limited Investor Presentation - November 2020

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation and the accompanying slides (the “Presentation”), which have been prepared by Galaxy Surfactants Limited. (the “Company”), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any s

  3. Slide 3: Q2 & H1 FY21 Performance Highlights

    Q2 & H1 FY21 Performance Highlights 3

  4. Slide 4: Q2 FY21: Key Developments

    Q2 FY21: Key Developments A Record Quarter – Highest Quarterly Volumes. Quarterly PBT Crosses Rs 100 Crores for the first time! Both segments – Performance Surfactants and Specialty Care Products register volume growth despite operational challenges Strong comeback by India – registers YOY 27% volum

  5. Slide 5: Volume Highlights Q2FY21

    Highest Quarterly Volumes: Q2FY21 Highlights Performance Surfactants Specialty Care Products Total Volume +15.3% +2.1% +10.4% 41,426 21,148 21,600 63,026 35,919 57,067 Volume Highlights Q2FY20 Q2FY21 Q2FY20 Q2FY21 Q2FY20 Q2FY21 India Market grew by 27.0% Africa Middle East Turkey grew by 6.1% Rest o

  6. Slide 6: Revenue Highlights Q2FY21

    Q2FY21 Highlights (YoY) Performance Surfactants Specialty Care Products Total Revenue^ +11.3% +11.6% +11.3% 445 279 723 400 250 650 Revenue Highlights Q2FY20 Q2FY21 Q2FY20 Q2FY21 Q2FY20 Q2FY21 EBITDA^ PAT +41.2% +21.9% 126 82 67 89 Rs. In Crores Q2FY20 Q2FY21 Q2FY20 Q2FY21 ^Includes other Income 6

  7. Slide 7: Volume Highlights H1FY21

    Volume: H1FY21 Highlights (YoY) Performance Surfactants Specialty Care Products Total Volume +11.7% -12.0% +2.8% 77,823 42,144 1,11,834 1,14,919 69,690 37,096 Volume Highlights H1FY20 H1FY21 H1FY20 H1FY21 H1FY20 H1FY21 India Market grew by 12.5% Africa Middle East Turkey grew by 8.1% Rest of the Wor

  8. Slide 8: Revenue Highlights H1FY21

    H1FY21 Highlights (YoY) Performance Surfactants Specialty Care Products Total Revenue^ +11.3% -14.5% +1.1% 890 516 1,316 1,331 800 441 Revenue Highlights H1FY20 H1FY21 H1FY20 H1FY21 H1FY20 H1FY21 EBITDA^ PAT +16.3% +15.6% 217 138 187 120 Rs. In Crores H1FY20 H1FY21 H1FY20 H1FY21 ^Includes other Inco

  9. Slide 9: Consolidated Profit & Loss Statement

    Consolidated Profit & Loss Statement Particulars (Rs. In Crores) Q2FY21 Q2FY20 Y-o-Y H1FY21 H1FY20 Y-o-Y Net Revenue from Operations 718.7 648.8 10.8% 1,325.8 1,313.8 0.9% Other Income 4.6 1.3 5.2 2.6 Total Revenue 723.3 650.1 11.2% 1,331.1 1,316.4 1.1% Cost of Material Consumed 457.7 433.0 857.3 87

  10. Slide 10: Consolidated Balance Sheet

    Consolidated Balance Sheet Particulars (Rs. In Crores) Sep'20 Mar'20 Particulars (Rs. In Crores) Sep'20 Mar'20 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 596.8 623.9 EQUITY Right-of-use assets 112.7 115.7 Equity Share Capital 35.5 35.5 Capital work-in-progress 90.4 66.0 Other Equity

  11. Slide 11: Consolidated Cash Flow

    Consolidated Cash Flow Half Year ended Particulars (Rs. In Crores) Sep'20 Sep'19 Cash Flow From Operating Activities : Profit After Tax 138.2 119.6 Operating Profit before working Capital changes 213.8 183.5 Net cash flows generated from/(used) in Operating Activities (A) 186.1 101.1 Net cash flows

  12. Slide 12: Standalone Profit & Loss Statement

    Standalone Profit & Loss Statement Particulars (Rs. In Crores) Q2FY21 Q2FY20 Y-o-Y H1FY21 H1FY20 Y-o-Y Net Revenue from Operations 489.6 446.3 9.7% 849.3 916.9 -7.4% Other Income -1.5 9.7 0.8 8.7 Total Revenue 488.1 456.0 7.0% 850.1 925.6 -8.2% Cost of Material Consumed 314.6 299.6 553.5 616.9 Emplo

  13. Slide 13: Standalone Balance Sheet

    Standalone Balance Sheet Particulars (Rs. In Crores) Sep'20 Mar'20 Particulars (Rs. In Crores) Sep'20 Mar'20 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 358.0 369.6 EQUITY Right-of-use assets 100.7 102.4 Equity Share Capital 35.5 35.5 Capital work-in-progress 85.0 61.4 Other Equity 9

  14. Slide 14: Standalone Cash Flow

    Standalone Cash Flow Full Year ended Particulars (Rs. In Crores) Sep'20 Sep'19 Cash Flow From Operating Activities : Profit After Tax 92.0 99.9 Operating Profit before working Capital changes 149.1 140.4 Net cash flows generated from/(used) in Operating Activities (A) 133.8 48.2 Net cash flows gener

  15. Slide 15: Business Overview

    Business Overview 15

  16. Slide 16: Truly Indian MNC…

    Truly Indian MNC… Leading manufacturer of Product applications across Preferred supplier to leading Ingredient for Home & Mass, Mass-tige & Prestige Multinational, Regional & Brand Custodian Personal care Industry (HPC) range of Customers Local FMCG Brands Globally Recognized Integrated Across Full

  17. Slide 17: …Vertically Integrated in HPC Industry

    …Vertically Integrated in HPC Industry 7 Strategically Located 205+ Product Grades Extensive R&D Capabilities Indigenous Facilities with Inhouse Project 74 Members, R&D Centre, Pilot Intellectual property Execution Capabilities Plant, Product Application 77 Approved; 13 Applied 5 in India, 1 in Egyp

  18. Slide 18: We grow faster than HPC FMCGs

    We grow faster than HPC FMCGs India’s Largest Manufacturer of Oleochemical based Surfactants and Speciality Care Products for Home Care and Personal Care Industries (HPC) Consumer to Innovation & Chemistry Technology 01 03 05 Global Supplier 02 Multiple 04 High Growth to Global Brands Products acros

  19. Slide 19: Our growth trajectory over Three Decades

    Our growth trajectory over Three Decades 1986: Incorporation of Company 1994: New plant set up at Tarapur 2004: setting up of EOU at Taloja 2011: Commissioning of Egypt and Jhagadia Plants 1984: New Plant at Tarapur for 1995: Acquisition of Galaxy Chemicals 2009: Ethoxylates, Phenoxyethanol, Sunscre

  20. Slide 20: Our focus is Personal & Home Care Segment

    Our focus is Personal & Home Care Segment Hair Care Oral Care Home Care Shampoos Toothpaste Carpet Cleaner Conditioners Tooth powder Toilet Cleaner Colorants Mouth wash Detergents Styling Gels Fabric Cleaner Glass / Floor Cleaner Mass Mass -tige Prestige Serving needs across Consumer Segments Mass M

  21. Slide 21: Consumer Benefits

    … with over 205+ Product Offerings Anionic Surfactants FAES, FAS, LABSA ✓ Foam and Dirt removal properties Performance Surfactants Non-Ionics Surfactants Ethoxylates ✓ Cosmetics and Personal care products as emulsifiers and solubilisers Betaines ✓ Dermatological properties to reduces skin irritation

  22. Slide 22: Our Business Segments…

    Our Business Segments… Performance Surfactants Speciality Care Products “Substantive Raw Material in Customer’s End-products” “Unique Functionality to Customer’s End-products” About Product ▪ Products are functional in nature where End- ▪ Niche & Premium products consumer require foaming & cleansing

  23. Slide 23: Our Global Footprints

    Our Global Footprints USA: TRI-K Industries-100% owned Manufacturing ✓ Netherlands R&D ✓ USA # Plants 1 TRI K Turkey China Industries Global # Employees 69 Headquarters Egypt Galaxy Marketing office ✓ Chemicals (Egypt) S.A.E. India Egypt:100% owned* FY20: Revenue Breakup Manufacturing ✓ India: Paren

  24. Slide 24: “Consumer to Chemistry”: Creation of Products

    “Consumer to Chemistry”: Creation of Products 77 approved Patents and 13 applied Idea Stage INDIA USA GLOBALLY EUROPE ROW Applied Feasibility Stage 16 18 5 8 13 Rs. 8 crs New product 77 Patents 13 Patent incurred to grades, since 2000 application Capability Stage pending enhance the process, R&D set

  25. Slide 25: …with World-class R&D facilities

    …with World-class R&D facilities Collaborative product development with Customers which helps Customers in choosing “Right Technology with Right Application” Inhouse R&D Team of 74 professionals comprising of doctorates, chemists and engineers Well-Equipped R&D Centre, Pilot Plant at Tarapur, Mahara

  26. Slide 26: State-of-the-art Manufacturing Facilities

    State-of-the-art Manufacturing Facilities Location No. of Units Installed Capacity Details ✓ 1 pilot plant for scale up and commercialisation of new Tarapur, Maharashtra 3 33,647 MTPA products rolling out from R&D activities ✓ Easy access to the Jawaharlal Nehru Port Trust, Navi Mumbai ✓ One of the

  27. Slide 27: 1750+ Clients across 80+ Countries

    1750+ Clients across 80+ Countries Procter & Colgate Reckitt Unilever Dabur Gamble Palmolive Benckiser Himalaya Henkel Emami Loreal CavinKare & Many more… Long term strategic relationship with all of the top 10 customers Strict qualifications and extensive collaboration with customers for end-produc

  28. Slide 28: Awards & Certifications

    Awards & Certifications: True recognition of Capabilities “Best Supply Partner”, 2015 2018 “Winning through Award of Global Performance” for Long Standing Partner Award Recognition from Innovation” at the Partner L’Oréal Asia Pacific 2012 Best Reliable Partner Award to Win, 2012 Awards “Certificate

  29. Slide 29: Accolades Received during FY20

    Accolades Received during FY20 Company won the Gold award for its innovative product TiLS (G) - An oil soluble surfactant at the HPCI Mumbai Conference 2020 • The Company has been Won the “Excellent Use of certified for the 2nd time IP in Innovation” Award at as Great Place to Work - the IP Summit &

  30. Slide 30: Management Team on Board

    Management Team on Board Mr. Unnathan Shekhar Promoter, Managing Director •Associated with Company since 1986 •Chemical Engineer, PGDM from IIM, Calcutta Mr. Natarajan K. Krishnan Mr. Kasargod Ganesh Kamath Executive Director, Chief Operating Officer Executive Director (Finance), Chief Financial Off

  31. Slide 31: Along with Guidance of Senior Board Members

    Along with Guidance of Senior Board Members Mr. Shekhar Ravindranath Warriar Chairman, Non-Executive Independent Director •Associated with Company since 2007 •More than 30 years with Unilever, India in various capacities Mr. Subodh S. Nadkarni Mr. Gopalkrishnan Ramakrishnan Mr. Shashikant R. Shanbha

  32. Slide 32: The 4 Cs: Our Core Strength

    The 4 Cs: Our Core Strength CHARACTER COMPETITIVENESS Transparent & Open, Respect & Adhering to Global Quality Value People, Dreaming & Standards, Supplying Envisioning , Conducting Customers Globally, Agile & Business with Integrity Nimble Footedness COMPETENCE COMFORT Respecting our Commitments, T

  33. Slide 33: Growth Strategy

    Growth Strategy 33

  34. Slide 34: Personal & Home Care: High Entry Barrier Businesses

    Personal & Home Care: High Entry Barrier Businesses Process Product Customers Chemical Engineering & inhouse project Wide spectrum of ingredients for Customer Centric Integrated solutions for execution Consumer categories / needs the HPC FMCG Industry Meeting pre-qualifications of the Product Qualit

  35. Slide 35: Our Growth Vision

    Our Growth Vision Sales R&D and Customer Market Strategy Profitability Optimization Innovation Wallet share Improve Financial Increased focus on Continue to focus Increase Wallet Mutually Performance high margin on R&D and Share with Existing Complimentary through Sales products in both Product Inno

  36. Slide 36: Financial Performance

    Financial Performance 36

  37. Slide 37: Managing Volatility in Raw Material Prices and Currency...

    Managing Volatility in Raw Material Prices and Currency... Fatty Alcohol Prices (USD / MT) INR / USD Prices LA Price USDINR 1,600 77.00 1,500 75.00 1,400 73.00 1,300 71.00 1,200 69.00 1,100 67.00 1,000 65.00 LA Price USDINR … through Robust Risk Management Practices Source: Market Prices – ICIS – LO

  38. Slide 38: Volume: FY20 Highlights (YoY)

    Volume: FY20 Highlights (YoY) Performance Surfactants Specialty Care Products Total Volume +6.0% +1.7% +4.4% 1,35,337 1,43,521 79,374 80,716 2,14,711 2,24,237 Volume Highlights FY19 FY20 FY19 FY20 FY19 FY20 India Market grew by 0.5% Africa Middle East Turkey grew by 9.4% Rest of the World grew by 2.

  39. Slide 39: FY20 Revenue Highlights

    FY20 Highlights (YoY) Performance Surfactants Specialty Care Products Total Revenue^ -8.8% -1.1% -6.0% 1,741 1,027 1,015 2,768 2,602 1,587 Revenue Highlights FY19 FY20 FY19 FY20 FY19 FY20 EBITDA^ PAT +4.7% +20.6% 358 375 230 191 Rs. In Crores FY19 FY20 FY19 FY20 As per Ind AS ^Includes other Income

  40. Slide 40: Our Performance Highlights

    Our Performance Highlights Revenue^ (Rs. In Crs) EBITDA^ (Rs. In Crs) PAT (Rs. In Crs) +7% 2,768 2,602 +14% 375 230 358 +28% 2,444 191 2,172 282 298 1,875 1,807 238 148 158 192 101 68 FY15 FY16 FY17* FY18* FY19* FY20* FY15 FY16 FY17* FY18* FY19* FY20* FY15 FY16 FY17* FY18* FY19* FY20* EBITDA per ton

  41. Slide 41: Our Balance Sheet Strength

    Our Balance Sheet Strength Debt/ Equity (x) Return on Equity (%) 1.1 28.8% 0.9 25.2% 24.4% 23.9% 24.7% 20.4% 0.7 0.5 0.3 0.4 FY15 FY16 FY17* FY18* FY19* FY20* FY15 FY16 FY17* FY18* FY19* FY20* Cash Flow from Operating Activities Return on Capital Employed (%) (Rs in cr) 316 283 26.8% 25.2% 23.9% 22.

  42. Slide 42: Consolidated Balance Sheet

    Consolidated Balance Sheet Particulars (Rs. In Crores) Mar'20 Mar’19 Particulars (Rs. In Crores) Mar'20 Mar’19 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 623.9 511.2 EQUITY Right-of-use assets 115.7 - Equity Share Capital 35.5 35.5 Capital work-in-progress 66.0 82.6 Other Equity 1,0

  43. Slide 43: Consolidated Cash Flow Statement

    Consolidated Cash Flow Statement Particulars (Rs. In Crores) 31-Mar-20 31-Mar-19 Cash Flow From Operating Activities : Profit After Tax 230.4 191 Adjustments for noncash items 143 165.8 Operating Profit before working Capital changes 373.4 356.8 Working capital adjustments 11.3 1.1 Cash flows genera

  44. Slide 44: Standalone Balance Sheet

    Standalone Balance Sheet Particulars (Rs. In Crores) Mar'20 Mar’19 Particulars (Rs. In Crores) Mar'20 Mar’19 ASSETS EQUITY AND LIABILITIES Property, Plant and Equipment 369.6 354.2 EQUITY Capital work-in-progress 61.4 40.2 Equity Share Capital 35.5 35.5 Right of use Asset 102.4 0.0 Other Equity 854.

  45. Slide 45: Standalone Cash Flow Statement

    Standalone Cash Flow Statement Particulars (Rs. In Crores) 31-Mar-20 31-Mar-19 Cash Flow From Operating Activities : Profit After Tax 182.2 168.5 Adjustments for noncash items 102.3 99.4 Operating Profit before working Capital changes 284.5 267.8 Working capital adjustments -14.6 40.2 Cash flows gen

  46. Slide 46: Thank You

    Thank Company : Investor Relations Advisors : You CIN No: L39877MH1986PLC039877 CIN - U74140MH2010PTC204285 Mr. Paritosh Srivastava Ms. Neha Shroff / Mr. Mandar Chavan Email: Paritosh.Srivastava@galaxysurfactants.com neha.shroff@sgapl.net / mandar.chavan@sgapl.net www.galaxysurfactants.com +91 77380

Galaxy Surfactants — Q2 FY2021 Earnings Presentation on 6ix